Mirum Pharmaceuticals Inc (MIRM)
25.72
+0.61
(+2.43%)
USD |
NASDAQ |
May 01, 16:00
25.72
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Total Liabilities (Quarterly): 397.95M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 397.95M |
| September 30, 2023 | 381.56M |
| June 30, 2023 | 364.98M |
| March 31, 2023 | 192.38M |
| December 31, 2022 | 210.87M |
| September 30, 2022 | 195.05M |
| June 30, 2022 | 186.55M |
| March 31, 2022 | 169.22M |
| December 31, 2021 | 174.44M |
| September 30, 2021 | 178.77M |
| Date | Value |
|---|---|
| June 30, 2021 | 151.93M |
| March 31, 2021 | 88.36M |
| December 31, 2020 | 68.77M |
| September 30, 2020 | 21.61M |
| June 30, 2020 | 19.56M |
| March 31, 2020 | 16.68M |
| December 31, 2019 | 16.36M |
| September 30, 2019 | 12.07M |
| June 30, 2019 | 132.22M |
| March 31, 2019 | 67.56M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.07M
Minimum
Sep 2019
397.95M
Maximum
Dec 2023
156.81M
Average
169.22M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences Inc | 38.84B |
| Vanda Pharmaceuticals Inc | 103.53M |
| Sarepta Therapeutics Inc | 2.405B |
| Puma Biotechnology Inc | 177.09M |
| Reneo Pharmaceuticals Inc | 18.83M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 646.62M |
| Shareholders Equity (Quarterly) | 248.67M |
| Debt to Equity Ratio | 1.232 |
| Current Ratio | 4.451 |
| Net Debt Paydown Yield | -4.44% |